Amplia Therapeutics Ltd. (AU:ATX)
ASX:ATX
Holding AU:ATX?
Track your performance easily

Amplia Therapeutics Ltd. (ATX) Income Statement

4 Followers

Amplia Therapeutics Ltd. Income Statement

Last quarter (Q4 2022), Amplia Therapeutics Ltd.'s total revenue was AU$―, a decrease of ― from the same quarter last year. In Q4, Amplia Therapeutics Ltd.'s net income was AU$―. See Amplia Therapeutics Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Mar 22Mar 21Mar 20Mar 19Mar 18
Total Revenue
------
Cost of Revenue
------
Gross Profit
------
Operating Expense
-AU$ 5.63MAU$ 3.87MAU$ 2.26MAU$ 1.94MAU$ 4.97M
Operating Income
-AU$ -5.63MAU$ -3.87MAU$ -2.26MAU$ -1.94MAU$ -4.97M
Net Non Operating Interest Income Expense
-AU$ -534.00AU$ 1.29KAU$ 3.72KAU$ 20.28KAU$ 26.97K
Other Income Expense
-AU$ 1.98MAU$ 1.59MAU$ 34.23KAU$ 50.47KAU$ 642.84K
Pretax Income
-AU$ -3.64MAU$ -2.28MAU$ -2.22MAU$ -1.87MAU$ -4.30M
Tax Provision
-AU$ 0.00AU$ 0.00AU$ 0.00AU$ 0.00AU$ 0.00
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
-AU$ -3.64MAU$ -2.28MAU$ -2.22MAU$ -1.87MAU$ -4.30M
Basic EPS
-AU$ -0.03AU$ -0.02AU$ -0.04AU$ -0.04-
Diluted EPS
-AU$ -0.03AU$ -0.02AU$ -0.04AU$ -0.04-
Basic Average Shares
-AU$ 145.55MAU$ 95.70MAU$ 52.96MAU$ 42.98M-
Diluted Average Shares
-AU$ 145.55MAU$ 95.70MAU$ 52.96MAU$ 42.98M-
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
------
Net Income From Continuing And Discontinued Operation
-AU$ -3.64MAU$ -2.28MAU$ -2.22MAU$ -1.87MAU$ -4.30M
Normalized Income
-AU$ -3.64MAU$ -2.28MAU$ -2.22MAU$ -1.87MAU$ -4.30M
Interest Expense
-AU$ 1.15K----
EBIT
-AU$ -3.64MAU$ -3.87MAU$ -2.26MAU$ -1.94MAU$ -4.97M
EBITDA
-AU$ -3.64MAU$ -3.87MAU$ -2.26MAU$ -1.94MAU$ -4.95M
Currency in AUD

Amplia Therapeutics Ltd. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis